Global Glaucoma Surgery Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

• In November 2023, Glaukos Corporation announced that the FDA has approved its iStent inject Trabecular Micro-Bypass System for the treatment of open-angle glaucoma (OAG).

• October 2023, Johnson & Johnson Vision announces that it has received CE Mark approval for its Xact Robotic System for Glaucoma Surgery. The Xact Robotic System is a robotic-assisted surgical platform that is designed to provide surgeons with greater precision and control during MIGS procedures.

The Global Glaucoma Surgery Market has been segmented by Target, Type Of Surgery, End User and Geography, target into angle-closure glaucoma, open-angle glaucoma, and others. Angle-closure glaucoma occurs when the drainage angle of the eye becomes blocked, leading to increased intraocular pressure (IOP). Surgical interventions aimed at relieving pressure, such as laser iridotomy or iridectomy, are often performed in these cases. Open-angle glaucoma, the most common form of the condition, results from a gradual clogging of the drainage channels, leading to elevated eye pressure. Surgical procedures for open-angle glaucoma include trabeculectomy, tube shunt surgery, and minimally invasive glaucoma surgery (MIGS). The "others" category includes rare forms of glaucoma, where specialized surgery is required to manage intraocular pressure. These target-specific surgeries aim to either restore the drainage system or reduce the production of aqueous humor to prevent optic nerve damage.

The market is also segmented by type of surgery into traditional glaucoma surgeries, minimally invasive glaucoma surgery (MIGS), and laser surgeries. Traditional glaucoma surgeries, such as trabeculectomy and glaucoma drainage device implantation, are used for severe cases of glaucoma that do not respond to medication or laser treatments. These procedures involve creating new drainage pathways for the fluid in the eye to lower intraocular pressure. Minimally invasive glaucoma surgery (MIGS) has become increasingly popular due to its less invasive nature, shorter recovery time, and fewer complications compared to traditional surgery. MIGS procedures include the implantation of microstents and minimally invasive drainage devices. Laser surgeries, such as laser iridotomy or selective laser trabeculoplasty (SLT), are often used to treat specific types of glaucoma, with laser energy being used to either open the drainage angle or improve fluid drainage, helping to lower IOP.

The end-user segment of the glaucoma surgery market includes hospitals and surgical centers, ophthalmic clinics, and other healthcare facilities. Hospitals and surgical centers are primary end-users, providing comprehensive surgical interventions for advanced glaucoma cases, including both traditional and MIGS procedures. These settings are equipped with specialized surgical tools and experienced ophthalmic surgeons to perform complex surgeries. Ophthalmic clinics cater to patients who need more routine treatments or follow-up care after surgery, focusing on less invasive procedures like laser treatments or monitoring IOP. Other healthcare facilities, such as outpatient centers or mobile clinics, are emerging as providers for simpler surgeries or diagnostic procedures, offering convenience for patients who do not require hospitalization. Geographically, North America and Europe hold a significant market share due to advanced medical infrastructure, while the Asia-Pacific region is experiencing rapid growth due to increasing awareness, rising healthcare standards, and a growing geriatric population.

Global Glaucoma Surgery Segment Analysis

In this report, the Global Glaucoma Surgery Market has been segmented by Target, Type Of Surgery, End User and Geography.

Global Glaucoma Surgery Market, Segmentation by Target

The Global Glaucoma Surgery Market has been segmented by Target into Trabecular Meshwork, Suprachoroidol Space and Others.

Trabecular Meshwor This is a key structure within the eye’s drainage system, located around the base of the cornea near the anterior chamber. It plays a crucial role in the regulation of intraocular pressure (IOP) by allowing aqueous humor to drain from the eye into the Schlemm’s canal. Dysfunction or blockage of the trabecular meshwork can lead to increased IOP, which is a primary risk factor for glaucoma. Treatments targeting the trabecular meshwork aim to enhance aqueous outflow, thereby reducing IOP and preventing damage to the optic nerve.

Suprachoroidal Spac The suprachoroidal space lies between the choroid and the sclera, forming a potential pathway for drug delivery and surgical interventions. This space has gained attention for its role in facilitating the delivery of drugs directly to the posterior segment of the eye, offering a minimally invasive route that bypasses the blood-ocular barriers. Treatments targeting the suprachoroidal space can effectively deliver medications for conditions such as uveitis, macular edema, and posterior segment inflammation.

The retinal pigment epithelium (RPE), and the vitreous humor. The ciliary body is involved in the production of aqueous humor and regulation of the lens's shape. Therapies aimed at the ciliary body often focus on reducing aqueous humor production to lower IOP in glaucoma patients. The RPE supports the visual cells in the retina, and its dysfunction is associated with diseases like age-related macular degeneration (AMD). Targeting the RPE can help in the management of retinal diseases. The vitreous humor, a gel-like substance filling the eye, can be a route for intravitreal injections used to treat retinal disorders.

Global Glaucoma Surgery Market, Segmentation by Type Of Surgery

The Global Glaucoma Surgery Market has been segmented by Type Of Surgery into Angle Closure Glaucoma Surgery, Aqueous Shunt Surgery, Laser Surgery and Others.

Angle Closure Glaucoma Surgery Angle closure glaucoma occurs when the drainage angle of the eye becomes physically blocked, preventing aqueous humor from exiting the eye, leading to a rapid increase in intraocular pressure (IOP). Surgical interventions for this condition often include laser peripheral iridotomy or surgical iridectomy. Laser peripheral iridotomy involves creating a small hole in the peripheral iris using a laser, allowing the aqueous humor to flow more freely and relieving the pressure. Surgical iridectomy is a similar procedure but performed with a surgical instrument rather than a laser. These procedures are critical in preventing acute angle closure attacks and managing chronic angle closure glaucoma.

Aqueous Shunt Surgery Also known as glaucoma drainage devices or tube shunt surgery, this procedure involves implanting a small tube and reservoir device to help drain excess aqueous humor from the eye. This surgery is typically considered for patients with refractory glaucoma, where other treatments have failed. The shunt helps divert the fluid to a different part of the eye, where it can be absorbed, thereby lowering IOP. Devices such as the Ahmed valve, Baerveldt tube, and Molteno implant are commonly used in these surgeries.

Laser Surgery Laser surgery for glaucoma includes procedures like selective laser trabeculoplasty (SLT), argon laser trabeculoplasty (ALT), and laser iridotomy. SLT and ALT target the trabecular meshwork to improve aqueous outflow and reduce IOP. SLT uses lower energy levels, making it a repeatable procedure if needed. Laser iridotomy, as mentioned earlier, is used primarily for angle closure glaucoma to create a passage in the iris for fluid drainage. These laser procedures are minimally invasive, offering quick recovery times and reducing the need for more invasive surgical approaches.

Global Glaucoma Surgery Market, Segmentation by End User

The Global Glaucoma Surgery Market has been segmented by End User into Hospital, Ambulatory Surgery Centers and Others.

Hospitals are the traditional and most comprehensive settings for performing ophthalmic surgeries. They are equipped with extensive medical resources, advanced surgical technology, and multidisciplinary teams capable of handling complex and high-risk cases. Hospitals are ideal for patients who may have additional medical conditions that require close monitoring and integrated care. They also provide the infrastructure needed for emergency procedures and postoperative care. However, surgeries in hospitals may involve longer waiting times and higher costs compared to other settings.

ASCs are specialized facilities designed to perform surgeries that do not require extended hospital stays. These centers focus on providing high-quality surgical care in a more convenient and cost-effective manner. Ophthalmic surgeries such as cataract surgery, glaucoma procedures, and laser treatments are commonly performed in ASCs. The advantages of ASCs include shorter waiting times, reduced risk of hospital-acquired infections, and lower costs. ASCs are equipped with state-of-the-art technology and staffed by specialized surgical teams, ensuring that patients receive focused and efficient care. This setting is particularly suitable for patients undergoing elective procedures and those who do not have significant comorbidities.

Ophthalmic clinics, academic medical centers, and specialized eye surgery centers. Private clinics often provide a more personalized experience, with direct access to highly experienced ophthalmic surgeons. These clinics may offer advanced diagnostic and surgical technologies, catering to patients seeking premium care. Academic medical centers, associated with universities, serve as training grounds for new ophthalmic surgeons and often participate in cutting-edge research. These centers are equipped to handle complex cases and offer patients access to the latest surgical techniques and clinical trials. Specialized eye surgery centers focus exclusively on ophthalmic procedures, providing a concentrated expertise in eye care and surgery.

Global Glaucoma Surgery Market, Segmentation by Geography

In this report, the Global Glaucoma Surgery Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

Global Glaucoma Surgery Market Share (%), by Geographical Region, 2024

North America, particularly the United States and Canada, is expected to remain a leading market for ophthalmic surgeries due to its advanced healthcare infrastructure, high healthcare expenditure, and a large aging population. The region has a high prevalence of eye conditions such as cataracts, glaucoma, and age-related macular degeneration, driving the demand for surgical interventions. Technological advancements, strong presence of key market players, and favorable reimbursement policies further boost the market.

Europe is another significant market for ophthalmic surgeries, with countries like Germany, the United Kingdom, France, and Italy leading the way. The aging population, high incidence of chronic eye diseases, and robust healthcare systems contribute to market growth. The European market is also driven by increasing awareness of eye health and the availability of advanced surgical options. Regulatory frameworks and supportive government initiatives in healthcare play a crucial role.

The Asia Pacific region is projected to experience the fastest growth in the ophthalmic surgery market during the forecast period. Factors such as a large and aging population, rising prevalence of eye disorders, and improving healthcare infrastructure contribute to this growth. Countries like China, India, Japan, and South Korea are at the forefront due to their expanding healthcare services and increasing investments in healthcare technology. The growing middle class and increasing awareness about eye health also fuel the demand for advanced surgical procedures.

The ophthalmic surgery market in the Middle East and Africa is growing, albeit at a slower pace compared to other regions. Challenges such as limited healthcare infrastructure, economic constraints, and varying access to medical care affect the market. However, there are pockets of growth driven by increasing government initiatives, rising healthcare investments, and growing awareness of eye health. Countries like the United Arab Emirates and Saudi Arabia are investing in healthcare modernization and expanding their medical tourism sectors, which include ophthalmic services. Over the next decade, the market is expected to grow as healthcare systems improve and more people gain access to eye care.

Latin America presents a mixed scenario for the ophthalmic surgery market. While countries like Brazil, Mexico, and Argentina have relatively developed healthcare systems and a growing middle class, the region also faces economic and political challenges that can impact market growth. Nevertheless, increasing healthcare investments, a rising burden of eye diseases, and improving medical infrastructure are driving the demand for ophthalmic surgeries.

This report provides an in depth analysis of various factors that impact the dynamics of Global Glaucoma Surgery Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Drivers, Restraints and Opportunity Analysis

Drivers

• Advancements in Surgical Techniques
• Rising Geriatric Population
• Growing Awareness and Screening Programs

• Development of Minimally Invasive Procedures - Minimally invasive procedures (MIPs) have revolutionized the field of surgery by reducing the need for large incisions, thereby minimizing patient trauma and accelerating recovery times. These techniques include laparoscopy, endoscopy, and robotic-assisted surgery, which utilize small incisions and specialized instruments to perform complex operations. The development of MIPs has been driven by advancements in medical technology, including high-definition imaging systems and precision instruments, allowing surgeons to perform detailed work through tiny openings. This has significantly decreased the risk of infection, reduced pain and scarring, and shortened hospital stays compared to traditional open surgeries.

  The evolution of minimally invasive techniques has been marked by continuous innovation and interdisciplinary collaboration. Surgeons, biomedical engineers, and researchers have worked together to refine existing methods and develop new tools that enhance the precision and safety of these procedures. For instance, robotic-assisted surgery, a prominent advancement, provides surgeons with enhanced dexterity and control, enabling them to perform delicate operations with greater accuracy. The integration of 3D imaging and real-time feedback systems has further improved outcomes, making procedures safer and more effective. Training programs and simulations have also been critical in ensuring that surgeons acquire the necessary skills to perform these advanced techniques.

  The impact of minimally invasive procedures on patient care and healthcare systems is profound. Patients benefit from quicker recoveries, less postoperative pain, and fewer complications, leading to a faster return to normal activities and improved overall quality of life. For healthcare systems, these procedures often translate to reduced costs due to shorter hospital stays and fewer postoperative complications. As the technology continues to advance, the scope of minimally invasive procedures is expanding, offering new possibilities for treating a wider range of conditions. The ongoing research and development in this field promise even greater innovations, further transforming the landscape of modern surgery and patient care.

Restraints

• Limited Access to Specialized Care
• Potential Complications from Surgery
• Stringent Regulatory Approval Processes

• Lack of Skilled Surgeons in Emerging Markets - The shortage of skilled surgeons in emerging markets presents a significant challenge to healthcare systems striving to provide quality surgical care to their populations. Several factors contribute to this shortage, including limited access to specialized training programs, inadequate infrastructure, and brain drain as skilled professionals migrate to more developed countries. As a result, many patients in these regions face barriers to accessing essential surgical services, leading to disparities in healthcare outcomes.

  Addressing the shortage of skilled surgeons in emerging markets requires a multifaceted approach that encompasses training, infrastructure development, and retention strategies. Investing in medical education and training programs tailored to the needs of these regions is crucial for building a sustainable workforce of skilled surgical professionals. Collaborations between local institutions and international partners can facilitate knowledge transfer and capacity building, empowering local healthcare providers to deliver high-quality surgical care.

  By addressing the shortage of skilled surgeons in emerging markets, healthcare systems can enhance their capacity to deliver essential surgical services, improve patient outcomes, and reduce disparities in access to care. Investing in the training and development of a robust surgical workforce is not only essential for meeting the current healthcare needs of these regions but also for building resilience and sustainability in the face of future challenges.

Opportunities

• Expansion into Emerging Markets
• Collaboration with Ophthalmology Clinics
• Growth of Outpatient Surgery Centers

• Increasing Investment in R&D Activities - Increasing investment in research and development (R&D) activities is vital for driving innovation, fostering economic growth, and addressing global challenges across various sectors. In recent years, there has been a growing recognition of the importance of R&D investment in driving technological advancement, enhancing competitiveness, and promoting sustainable development. Governments, businesses, and academic institutions are increasingly prioritizing R&D as a means to stimulate innovation and create value in the economy.

  One of the primary benefits of increasing R&D investment is the potential for breakthrough discoveries and technological advancements that can lead to the development of new products, processes, and services. These innovations not only drive economic growth but also improve quality of life, address societal needs, and tackle pressing global challenges such as climate change, healthcare, and energy sustainability. Additionally, R&D investment plays a crucial role in maintaining competitiveness in an increasingly globalized and knowledge-driven economy, enabling countries and industries to stay ahead of the curve and adapt to rapid technological changes.

  Increasing R&D investment can stimulate collaboration and knowledge sharing among stakeholders, fostering an environment conducive to innovation and entrepreneurship. By supporting research initiatives, fostering partnerships between academia and industry, and providing funding for startups and small businesses, governments can create ecosystems that encourage the translation of research findings into real-world applications and commercialization. This not only creates economic value but also spurs job creation, enhances productivity, and fosters a culture of innovation and creativity. In conclusion, increasing investment in R&D activities is essential for driving innovation, economic growth, and societal progress. By prioritizing R&D investment, countries and industries can unlock new opportunities, address global challenges, and build a sustainable future for generations to come. Governments, businesses, and academic institutions must work together to create conducive environments for R&D, foster collaboration, and support the translation of research into tangible outcomes that benefit society as a whole.

Key players in Global Glaucoma Surgery Market include:

• Santen Pharmaceutical
• AqueSys
• Iridex Corporation
• OCULUS Optikgeräte Gmbh
• Molteno Ophthalmic Limited
• New World Medical
• Sight Sciences
• Ivantis

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis